EUROPLASMA: Update to the OCABSA bond issuance schedule

Europlasma has adjusted the specifications of tranches 22 and 23 of its convertible bonds, increasing the nominal value of each tranche to €1.5 million. This change is accompanied by the addition of 100 extra bonds per tranche, along with a 10% fee in the form of 30 additional bonds per tranche.

These changes are intended to support the development of the group, in particular by diversifying the activities of FDB Industries and Valdunes Industries towards the defence sector, as well as increasing the capacity of the Forges de Tarbes.

Europlasma warns of potential pressure on the share price due to the rapid release of securities onto the market. The issuance does not require a prospectus approved by the French Financial Markets Authority (AMF), and the financing structure could accelerate the dilution of existing shareholders.